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Abstract  Retinal  arterial  macroaneurysm  is  an  acquired,  focal  dilation  of  a  retinal  artery,
typically occurring  within  the  ﬁrst  three  bifurcations  of  the  central  retinal  artery.  The  clinical
presentation  of  a  retinal  arterial  macroaneurysm  is  highly  variable,  making  initial  diagnosis
difﬁcult and  differentials  many.  Identiﬁcation  of  retinal  arterial  macroaneurysms  is  crucial  to
appropriately  co-manage  with  the  primary  care  physician  for  hypertension  control.  Prognosis  is
generally good  and  observation  is  often  an  adequate  treatment.  However,  in  cases  of  macular
threat or  involvement,  some  treatment  options  are  available  and  referral  to  a  retinal  specialist
is indicated.
© 2013  Spanish  General  Council  of  Optometry.  Published  by  Elsevier  España,  S.L.  All  rights
reserved.
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Resumen  El  macroaneurisma  de  la  arteria  retiniana  es  una  dilatación  focal  y  adquirida  de
una arteria  retiniana,  que  se  produce  normalmente  en  de  las  primeras  tres  bifurcaciones
de la  arteria  central  de  la  retina.  La  presentación  clínica  del  macroaneurisma  de  la  arteria
retiniana es  altamente  variable,  lo  que  diﬁculta  el  diagnóstico  inicial  dadas  las  muchas
características  diferenciales.  La  identiﬁcación  de  dichos  macroaneurismas  es  esencial  para
poder coordinar  con  el  facultativo  de  atención  primaria  el  control  de  la  hipertensión.  ElExudación,
hipertensión pronóstico  es  generalmente  bueno,  siendo  a  menudo  la  observación  el  tratamiento  adecuado.
Sin embargo,  en  casos  de  amenaza  o  afectación  macular,  las  opciones  de  tratamiento  son
variables,  recomendándose  la  derivación  al  especialista  de  la  retina.
© 2013  Spanish  General  Council  of  Optometry.  Publicado  por  Elsevier  España,  S.L.  Todos  los
derechos  reservados.
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ntroduction
etinal  arterial  macroaneurysm  (RAM)  is  described  as  an
cquired,  focal  dilation  of  a  retinal  artery,  typically  occur-
ing  within  the  ﬁrst  three  bifurcations  of  the  central  retinal
rtery.1--4 RAMs  can  present  with  a  wide  variety  of  retinal
ndings  and  are  often  misdiagnosed  at  initial  presentation.3
ormation  of  a  RAM  is  believed  to  result  from  a  com-
ined  process  of  arteriosclerosis  and  hypertension.  Up  to
5%  of  patients  presenting  with  RAM  are  shown  to  have
ypertension.1,3,4 Accurate  identiﬁcation  of  RAM  is  crucial
o  appropriately  co-manage  these  patients  with  the  pri-
ary  care  physician.3,4 Prognosis  for  RAM  is  favorable;  most
ndergo  spontaneous  resolution  over  a  period  of  months.1,2,4
n  many  instances  observation  is  adequate  management.
owever,  in  cases  of  macular  involvement  referral  to  a
etinal  specialist  is  often  warranted  as  a  variety  of  treat-
ent  options  exist.3,4 In  this  review,  we  aim  to  highlight  the
ariable  presentation  of  this  frequently  misdiagnosed  condi-
ion  and  provide  an  update  on  current  treatment  options.
e  also  include  a  case  report  of  a  ruptured  RAM  with  macular
nvolvement,  co-managed  between  optometry  and  ophthal-
ology.
istory and epidemiology
linical  descriptions  of  retinal  arterial  aneurysms  have
een  reported  in  the  literature  since  the  late  1800s,1 but
n  1973  Robertson2 was  the  ﬁrst  to  describe  the  clinical
haracteristics  and  apply  the  term  retinal  arterial  macroa-
eurysm.  Retinal  arterial  macroaneurysms  are  described  as
n  acquired,  focal  dilation  of  a  retinal  artery,  typically
ccurring  within  the  ﬁrst  three  bifurcations  of  the  central
etinal  artery.4 They  are  commonly  found  at  arteriovenous
rossings4,6 or  directly  at  a  bifurcation.5 Although  RAMs  are
sually  a  solitary,  unilateral  ﬁnding,  multiple  RAMs  may  be
bserved  in  15--20%  of  cases  and  bilateral  disease  occurs
n  up  to  10%  of  cases.5 It  is  believed  that  less  structural
upport  of  arteries  exist  at  arteriovenous  crossings  due  to
he  absence  of  the  adventitial  layer,  making  these  areas
ore  prone  to  aneurysm  formation.6 Two  types  of  RAM  are
escribed  in  the  literature,  fusiform  (cuffed)  and  saccu-
ar  (blowout).7 Fusiform  RAMs  are  described  as  an  uniform
idening  of  the  retinal  artery  while  saccular  RAMs  are
escribed  as  a  localized  outpouching  of  the  arterial  wall.8
RAMs  are  most  commonly  observed  in  elderly  females,
ith  most  studies  reporting  an  age  range  from  66  to  74
ears  old,  and  a  female  preponderance  of  about  70%.3,6,8--11
ypertension  is  the  most  common  systemic  condition  asso-
iated  with  RAM;  approximately  75%  of  presenting  patients
ave  hypertension.1,6,11 Other  associated  conditions  include
rteriosclerosis  and  abnormal  lipid  levels.3
athophysiology
he  pathophysiology  behind  the  formation  of  RAMs  is  not
ully  understood.  RAMs  result  from  a  focal  weakness  in  the
rterial  wall,  which  is  believed  to  be  the  combined  result
f  aging  and  atherosclerosis.  With  aging,  atrophy  of  the
uscularis  layer  leads  to  thinning  and  ﬁbrosis  of  the  ves-
el  wall  causing  decreased  elasticity  within  the  artery.1 This
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equence  of  events  creates  an  increased  susceptibility  to
rterial  dilation  from  raised  hydrostatic  pressure,  as  seen
n  hypertension.1,8 The  reason  and  the  localization  of  these
ocal,  as  opposed  to  widespread,  weaknesses  develop  are
ot  entirely  understood.  It  is  suggested  that  these  are  areas
here  emboli  have  lodged  or  local  thrombosis  has  occurred.
istological  studies  of  RAMs  have  shown  both  thrombus
nd  cholesterol  crystals  partially  ﬁlling  the  macroaneurysm,
ending  support  to  these  theories.1
linical signs and symptoms
he  clinical  presentation  of  RAM  varies  greatly  and  is
requently  described  as  a  masquerade  syndrome.  A  retro-
pective  study  by  Lavin  and  colleagues  in  19876 found  RAMs
o  be  misdiagnosed  at  a  rate  of  75%  at  ﬁrst  presentation  and
 more  recent  study  by  Moosavi  et  al.  reported  only  4  of
4  cases  (28%)  listing  RAM  as  the  initial  diagnosis.8 Patients
ay  present  with  an  acute  or  insidious  loss  of  vision  when
emorrhage  or  edema  involves  the  macula  or  when  vitre-
us  hemorrhage  is  present.  But  often  RAMs  are  discovered
n  routine  ophthalmic  examination,  presenting  without  any
ymptoms  at  all.5
The  clinical  appearance  of  RAMs  is  also  highly  variable.
raditionally,  we  expect  to  see  blood  in  multiple  layers,
ncluding  subretinal,  intraretinal,  preretinal  and  vitreal.4,12
his  is  expected  as  arteries  are  high  ﬂow  vessels,  thus
hen  an  aneurysm  ruptures,  it  does  so  under  signiﬁcant
ressure,  pushing  blood  into  many  retinal  layers.  Often  the
acroaneurysm  can  be  seen  as  a  rounded  dilation  within  an
rtery1 and  spontaneous  pulsations  have  been  documented.
here  is  some  thought  that  spontaneous  pulsation  could
e  an  indication  of  pending  rupture,  however  this  idea  has
een  challenged.5 Exudation  may  also  be  present,  usually
een  in  a  circinate  pattern  surrounding  the  aneurysm  but
ay  also  be  found  in  the  macular  region.3 Macular  edema
an  occur  with  or  without  exudation  and  neurosensory
etachments  may  also  be  seen.5
ifferential diagnoses
ifferential  diagnoses  of  RAM  vary  depending  on  the  clini-
al  presentation  of  the  case.  The  predominating  feature  --
bnormal  vessel  structure,  hemorrhage,  or  exudates,  and
he  retinal  location  --  is  going  to  alter  the  differential
iagnoses  considered  in  each  case.  Submacular  blood  and
xudation  are  often  confused  with  age  related  macular
egeneration  (ARMD).5 The  bilateral  nature  of  ARMD  can
elp  rule  this  out;  however  in  patients  who  may  additionally
ave  ARMD,  a  ﬂuorescein  or  indocyanine  green  angiogram
an  help  determine  a  diagnosis.3,5 Dense  subretinal  blood
ay  be  ﬂat  or  elevated  and  mimic  a  malignant  melanoma.  In
uch  a  case,  ultrasound,  ﬂuorescein  angiography  (FA),  mag-
etic  resonance  imaging  and  observation  can  be  considered
o  help  determine  a  diagnoisis.3 Differentials  for  the  appear-
nce  of  pre-retinal  hemorrhage  in  the  macular  region,  such
s  seen  in  our  case,  include  valsalva  retinopathy,  posterior
itreous  detachment  with  secondary  preretinal  hemorrhage,
roliferative  diabetic  retinopathy  and  exudative  ARMD.  Val-
alva  retinopathy  presents  with  pre-retinal  hemorrhage  near
he  macula  and  may  be  unilateral  or  bilateral  in  nature.
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There  is  no  age,  racial  or  sex  predilection  but  a  history  of
valsalva  maneuver  is  elicited.13 Posterior  vitreous  detach-
ment  (PVD)  with  pre-retinal  hemorrhage  could  also  mimic
our  case  presentation.  Symptoms  will  include  ﬂashes,  a
new,  often  large  ﬂoater  is  described  and  a  PVD  is  present
on  DFE.  Proliferative  diabetic  retinopathy  (PDR)  can  cause
pre-retinal  hemorrhage  and  while  PDR  may  be  asymmet-
ric,  it  would  be  present  bilaterally.  There  is  most  often
a  corresponding  history  of  diabetes  mellitus.  Presence  of
vitreous  hemorrhage  could  be  confused  for  an  acute  poste-
rior  vitreous  detachment,  proliferative  diabetic  retinopathy,
or  retinal  vein  occlusion.3,5 A  good  case  history  and  fun-
dus  exam  of  the  fellow  eye  are  helpful  when  considering  a
unilateral  versus  bilateral  disease  process.  When  exudation
dominates  the  clinical  picture  additional  conditions  to  con-
sider  include  Coat’s  disease,  Leber’s  milliary  aneurysms  and
angiomatosis  retinae.2 While  similar  in  appearance,  the  epi-
demiology  of  these  conditions  differ.  Coat’s  disease,  Leber’s
and  angiometosis  retinae  typically  occur  in  young,  other-
wise  healthy  individuals3 unlike  RAM,  seen  in  the  elderly
female  population.  Speciﬁcally,  Coat’s  disease  affects  young
males  in  the  ﬁrst  decade  and  the  aneurismal  dilations  affect
veins,  capillaries  and  arterioles.  Peripheral  retinal  capillary
hemangiomas  with  tortuous  feeding  vessels  are  character-
istic  of  angiometosis  retinae,3 unlike  RAM  which  tend  to
occur  in  the  posterior  pole  within  the  ﬁrst  three  orders  of
the  central  retinal  artery.1 Additional  differential  may  be
considered  depending  on  the  unique  presentation  of  each
case.
Diagnostic testing
Ancillary  testing  can  help  differentiate  macroaneurysms
from  the  other  retinal  conditions  they  may  mimic.  Fluo-
rescein  angiography  can  be  especially  useful  if  the  RAM  is
obscured  or  involuted.4 FA  of  fusiform  RAMs  shows  rapid  ﬁll-
ing  in  early  arterial  phase,  while  saccular  RAMs  show  minimal
early  ﬁlling,  with  full  ﬁlling  in  the  middle  to  late  phases.  Fill-
ing  in  the  early  arterial  phase  may  be  segmental  in  nature
due  to  clot  formation  or  scarring  from  blockage  of  the  lumen
by  thrombosis  or  endothelial  cell  formation.  RAM’s  that  have
‘‘self-sealed’’  may  show  no  leakage,14 while  others  may
exhibit  late  leakage.4 FA  may  also  reveal  changes  in  capillar-
ies  adjacent  to  the  RAM,  including  dilation,  telangiectasia,
and  closure.14
In  cases  where  hemorrhage  blocks  visualization  of  the
aneurysm  and  imaging  with  ﬂuorescein  angiography  is  incon-
clusive,  ICG  may  be  more  useful.4,14 The  absorption  and
emission  peaks  of  ICG  dye  are  in  the  near-infrared  spectrum
which  allows  better  visualization  through  dense  hemor-
rhage,  exudates,  and  retinal  pigment  epithelial  changes.
RAMs  show  well-deﬁned  areas  of  hyperﬂuoresence  with  ICG
angiography  and  ICG  can  pinpoint  the  exact  location  of  the
macroaneurysm  in  cases  of  dense  hemorrhage,  which  may
be  useful  in  planning  surgery  or  treatment.14
Optical  coherence  tomography  (OCT)  is  beneﬁcial  to
diagnose  and  monitor  associated  retinal  edema  from  RAM
and  to  determine  the  presence  and  extent  of  subretinal
ﬂuid,  macular  edema  and  hemorrhage.  More  recently,  inves-
tigators  have  identiﬁed  characteristics  of  macroaneurysms
imaged  with  OCT  and  are  looking  at  OCT  for  conﬁrmation
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f  the  diagnosis  versus  intravenous  contrast  imaging.15 OCT
cans  directed  through  the  macroaneurysm  show  an  abnor-
al  saccular  expansion  of  the  arterial  vessel  wall  with  an
nlarged  lumen  located  in  the  inner  retinal  layers.  The  RAM
levates  the  internal  limiting  membrane  and  ganglion  cell
ayers  and  produces  a  shadowing  effect  of  deeper  retinal
ayers.15
A  study  by  Lee  et  al.  demonstrated  that  SD-OCT  may  be
 useful  tool  for  the  prediction  of  treatment  responses  of
AMs  by  analyzing  the  ﬁlling  pattern  of  lumen  as  early  as
 h  after  the  laser  photocoagulation.  This  case  series  found
hat  SD-OCT  of  a  RAM  showing  complete  ﬁlling  of  the  lumen
ith  thrombus  immediately  after  laser  treatment  suggests  a
omplete  obstruction  of  RAM  and  was  correlated  with  favor-
ble  clinical  outcome.  The  authors  postulated  that  if  SD-OCT
eveals  a  RAM  with  residual  ﬂuid  collection  in  the  lumen,  it
ould  indicate  a  persistent  blood  ﬂow  in  the  aneurysm  and
ncomplete  treatment.16 Due  to  the  non-invasive  nature  of
his  procedure,  OCT  can  be  an  effective  tool  for  detecting
AM  and  monitoring  the  condition  and  its  complications  over
ime.15,16 However,  visualization  may  be  limited  by  dense
re-retinal  or  vitreous  hemorrhage,15 as  in  our  case  where
o  macroaneurysm  could  be  visualized  on  OCT.
linical course
n  the  majority  of  patients,  RAMs  resolve  spontaneously
ithout  signiﬁcant  sequellae.4,17 Complications  are  not  com-
on,  but  they  do  occur.  The  most  common  complication
s  vision  loss  from  hemorrhagic  complications  or  chronic
acular  edema.  Eyes  with  vitreous  and  pre-retinal  hemor-
hage  tend  to  recover  better  visual  acuity  compared  to  eyes
ith  macular  edema  and  deeper  retinal  hemorrhaging.  Sub-
acular  hemorrhage  yields  the  poorest  visual  outcome.18
ubretinal  blood  damages  the  photoreceptors  from  a  com-
ined  effect  of  chemical  toxins,  outer-retinal  shear  forces
nd/or  a  barrier  effect  limiting  diffusion  between  the
hotoreceptors  and  retinal  pigment  epithelium.4,18,19 Per-
anent  damage,  resulting  in  permanent  vision  loss  is
hought  to  occur  in  as  little  as  2  days18 and  deﬁnitely
ithin  2  weeks.4 Macular  holes  and  subretinal  neovascu-
arization  have  rarely  been  reported  to  occur  as  a  result
f  submacular  hemorrhage.20 Chronic  macular  edema  and
ense  long-standing  exudates  can  also  cause  a  permanent
oss  of  best  corrected  visual  acuity.4,8 Additional  reported
omplications  include  secondary  angle  closure  glaucoma,
erous  or  hemorrhagic  retinal  detachments  and  retinal  vein
cclusion.4,11
reatment and management
reatment  and  management  of  RAMs  depend  on  the  clini-
al  appearance  and  associated  complications.  The  majority
f  RAMs  will  follow  a  benign  course  of  thrombosis,  ﬁbro-
is  and  spontaneous  resolution  with  return  to  prior  visual
cuity.1,14,17 For  this  reason,  asymptomatic  RAMs  without
emorrhage  or  exudates  can  be  observed  every  6  months
ntil  involution.4,17 In  cases  of  ruptured  RAM  with  hemor-
hage  and/or  exudation,  if  the  macula  is  not  involved  and
here  appears  to  be  little  threat  of  macular  involvement,
bservation  is  adequate  management,  with  close  follow-up
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t  1  month,  then  every  1--3  months  until  involution.3,14,17
or  symptomatic  RAMs  with  decreased  vision  secondary
o  intraretinal,  preretinal,  or  vitreous  hemorrhage,  close
bservation  over  the  ﬁrst  3  months  is  often  advocated  due
o  the  high  frequency  of  spontaneous  resolution  and  limited
equellae  from  these  ﬁndings.1,14 Alternatively,  these  cases
an  be  referred  to  a  retinal  specialist  for  consideration
f  earlier  treatment.8 Referral  may  depend  on  the  indi-
idual  patient  and  their  visual  needs.  Lastly,  in  cases  of
irect  macular  involvement  of  exudation,  edema,  subreti-
al  hemorrhage  or  sensory  detachment,  referral  to  a  retinal
pecialist  is  indicated  as  some  form  of  treatment  is  often
ecommended.1,14
Many  treatments  exist  for  RAM,  yet  no  established  treat-
ent  protocol  has  been  determined.  Photocoagulation  may
e  considered,  usually  when  edema  or  exudation  is  causing
ecreased  visual  acuity.  Photocoagulation  may  be  performed
irectly  to  the  macroaneurysm  with  intent  to  speed  invo-
ution  and  decrease  leakage.  Alternatively,  indirect  laser
ay  be  applied  to  the  adjacent  retina  with  aim  to  stop  or
ecrease  leakage  progression  toward  the  macula.17 A  supe-
ior  method  of  photocoagulation  has  yet  to  be  determined5
ut  there  seems  to  be  trend  toward  favoring  indirect.17
here  remains  no  deﬁned  criteria  for  the  use  of  laser
hotocoagulation;  there  are  no  large,  prospective  trials
f  photocoagulation  and  smaller  case  series  have  yielded
ixed  results  questioning  if  there  is  any  beneﬁt.5,21 Reported
omplications  of  laser  photocoagulation  include  arteriolar
cclusion,  retinal  traction,  increased  exudation,17 severe
apillary  drop  out  and  subretinal  scarring.21 Recently,  a
ewer  method  of  photocoagulation,  termed  subthreshold
aser,  was  reported.  The  goal  of  subthreshold  laser  treat-
ent  (STLT)  is  to  decrease  complications  of  traditional  laser
y  reducing  laser  exposure  and  utilizing  a  subvisible  clinical
ndpoint.  Early  data  is  hopeful;  a  pilot  study  of  nine  patients
ndergoing  STLT  for  RAM  complications  showed  cessation
f  leakage  in  all  patients  with  improved  BCVA  and  no  evi-
ence  of  arteriolar  occlusion,  increased  retinal  exudation
r  traction.22
Recently,  intravitreal  injections  of  anti-vascular  endothe-
ial  growth  factor  (VEGF)  have  been  studied  as  a  treatment
ption  for  RAM  with  macular  hemorrhage  or  secondary
acular  edema.23,24 In  a  case  series  by  Cho  et  al.,  treat-
ent  of  symptomatic  macular  edema  and  or  hemorrhage
ith  intravitreal  bevacizumab  was  compared  to  observation.
hile  there  was  no  signiﬁcant  difference  between  groups
or  ﬁnal  best  corrected  visual  acuity  and  central  macular
hickness,  the  treatment  group  did  show  faster  resolution
f  retinal  hemorrhage  and  visual  acuity  than  the  observa-
ional  group.23 Pichi  et  al.  treated  symptomatic  RAMs  with
emorrhagic,  exudative  or  serous  macular  complications
ith  3-monthly  injections  of  intravitreal  bevacizumab  and
bserved  94%  closure  of  the  RAM  at  week  6  (after  2
njections)  and  100%  of  patients  had  complete  resolution
f  macular  edema  4  weeks  after  the  ﬁnal  bevacizumab
njection.25 The  mechanism  of  action  of  anti-VEGF  medi-
ation  for  the  treatment  of  RAM  is  unclear.  VEGF  causes
asodilation  by  stimulating  endothelial  production  of  nitric
xide  and  is  known  to  be  related  to  the  activation  of  coag-
lation  cascades.  Vasoconstriction  has  been  reported  to
educe  macular  edema  independent  of  the  effect  of  vas-
ular  permeability.23 Cho  et  al.  propose  that  treatment
b
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ith  anti-VEGF  agents  may  reduce  edema  by  reducing
itric  oxide  and  causing  vasoconstriction.  Further,  inhibi-
ion  of  VEGF  may  alter  the  balance  between  coagulation
nd  ﬁbrinolysis  thus  facilitating  the  clearing  of  retinal  hem-
rrhage.
Pars  plana  vitrectomy  (PPV)  may  be  considered  in  cases  of
on-clearing  vitreous  hemorrhage,  usually  after  3  months  of
bservation.5,26 Alternatively,  PPV  may  be  performed  ear-
ier  to  allow  removal  of  pre-retinal  blood  when  speedier
isual  recovery  is  desired  and/or  visualization  of  the  macula
s  inhibited,  thereby  making  the  identiﬁcation  of  additional
acular  pathology  difﬁcult.  As  discussed  previously,  prereti-
al  blood  typically  resolves  with  observation  alone  but  it
ay  take  several  months.26 Additionally,  the  presence  of
ense  pre-retinal  blood  can  cause  epiretinal  membrane  for-
ation  and  have  toxic  effects  to  the  retinal  tissue.12,26,27 It
as  for  these  reasons  that  a prompt  vitreous  surgery  was
erformed  in  our  case.  However,  because  visual  prognosis  is
enerally  favorable  with  observation  alone,  careful  consid-
ration  of  the  complications  associated  with  PPV  is  prudent
nd  should  be  weighed  against  the  beneﬁts.3 Post-operative
ataract  progression  is  a  well-documented  complication
f  PPV,  requiring  a  second  surgical  procedure  with  addi-
ional  risks  to  maintain  visual  gain.26,27 Other  possible
erious  complications  of  PPV  include  retinal  breaks,  reti-
al  detachment,  active  bleeding,  and  endophthalmitis.26,27.
dditionally,  macular  hole  is  a complication  of  PPV  speciﬁ-
ally  for  treatment  of  pre-retinal  hemorrhage  secondary  to
AM.28
Preretinal  hemorrhage  may  also  be  treated  by  pulsed
eodymium:yttrium  aluminum  garnet  (Nd:YAG)  laser
embranotomy.12,29 Again,  the  goal  in  treating  prereti-
al  hemorrhages  is  to  speed  visual  recovery,  decrease
omplications  of  stagnant  preretinal  blood,  and  increase
isualization  of  the  retina.  Nd:YAG  membranotomy  causes
 focal  disruption  to  the  inner  limiting  membrane  of
he  retina  allowing  the  hemorrhage  to  dissipate  into  the
itreous  for  quicker  absorption.5 Complications  include  a
econdary  non-clearing  vitreous  hemorrhage  that  requires
itrectomy  to  remove,  macular  hole,  retinal  detachement29
nd  epiretinal  membrane  formation.26
In  cases  of  submacular  hemorrhage  pneumatic  dis-
lacement  or  submacular  surgery  may  be  performed.
neumatic  displacement  uses  injected  perﬂuorocarbon  gas
nd  downgaze  positioning  to  displace  the  hemorrhage
ut  of  the  macula,  thereby  reducing  complications  in
he  macula  from  the  presence  of  subretinal  blood.30
his  procedure  has  been  reported  with  and  without  the
se  of  intravitreal  tissue  plasminogen  activator.31 Ongo-
ng  Phase  II  clinical  trials  are  there  to  establish  efﬁcacy
s  a  treatment  option  for  submacular  hemorrhage  and
o  determine  the  optimal  position  of  gaze  for  max
isplacement.30 An  alternative  treatment  for  subretinal
emorrhage  is  submacular  surgery.  This  procedure  includes
 pars  plana  victrectomy  followed  by  surgical  drainage
f  submacular  blood  via  a  retinotomy,  ﬂuid-air  exchange
nd  insufﬂation  with  intravitreal  gas.  Facedown  position-
ng  for  1  week  is  required.31 Complications  with  these
wo  procedures  are  the  same,  including  cataract,  retinal
reaks,  and  retinal  detachment;  however  some  speculate
omplications  with  pneumatic  displacement  should  occur
ess  frequently.32
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Case example
A  74-year-old  African  American  female  presented  with
sudden  vision  loss  in  her  left  eye  (OS)  of  3  days  dura-
tion.  She  described  a  centralized,  dark  circle  blocking  her
vision.  She  denied  ﬂashes  or  pain  and  reported  that  until
4  days  ago  vision  had  been  equal  between  her  two  eyes.
Medical  history  was  notable  for  hypertension,  diagnosed  2
years  ago,  for  which  she  was  taking  lisinopril,  metopro-
lol  and  81  mg  aspirin.  She  reported  poor  compliance  with
these  medications.  Family  and  social  history  were  nega-
tive.
Best  corrected  visual  acuities  were  20/25  right  eye  (OD)
and  hand  motion  OS.  Pupils  were  equal,  round  and  reactive
to  light  without  afferent  pupillary  defect.  Ocular  motility
was  full  in  both  eyes  (OU)  and  confrontation  visual  ﬁelds
were  full  to  ﬁnger  count  OD,  OS.  Anterior  segment  examina-
tion  was  unremarkable  in  each  eye.  Goldmann  applanation
tonometry  readings  were  14  mmHg  OD,  OS.  Blood  pres-
sure  measured  196/90  mmHg.  Upon  questioning,  the  patient
denied  having  symptoms  of  elevated  blood  pressure,  includ-
ing  headache,  dizziness,  nausea,  chest  pain,  paresthesias
and  shortness  of  breath.  She  reported  that  she  did  not  take
her  hypertension  medications  that  day.
Dilated  fundus  examination  OD  revealed  a  healthy  optic
nerve  and  clear  vitreous.  The  macular  area  was  ﬂat  and
clear,  save  for  a  single  microaneurysm  superior  nasal
to  the  fovea.  Vasculature  showed  generalized  attenuation  of
the  arteries  and  mild  tortuosity.  The  peripheral  retina  was
intact  360◦.  Dilated  fundus  examination  OS  revealed  clear
vitreous  and  healthy  optic  nerve.  Macular  evaluation  showed
a  large  pre-retinal  hemorrhage  measuring  approximately
3  ×  2  disk  diameters.  Areas  of  intraretinal  and  subretinal
blood  were  noted  along  the  perimeter  of  the  pre-retinal
hemorrhage  (Fig.  1).  Vasculature  was  mildly  tortuous  and
showed  generalized  arterial  attenuation,  consistent  with  the
appearance  of  the  right  eye.  Periphery  was  intact  360◦.  Due
to  the  multilevel  retinal  hemorrhage,  a  tentative  diagnosis
of  retinal  artery  macroaneurysm  was  made.  Spectral  domain
optical  coherence  tomography  (SD  OCT)  was  taken  through
Figure  1  Left  fundus  at  presentation.  A  large  preretinal
hemorrhage  obscures  visualization  of  the  macula.  Areas  of
intraretinal  and  subretinal  blood  are  also  seen.
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he  area  of  the  suspected  macroaneurysm,  superior  tempo-
al  to  the  fovea.  It  demonstrated  dense  pre-retinal  and  inner
ayer  hyper-reﬂectivity  with  subsequent  outer  layer  shad-
wing  consistent  with  a  dense  pre-retinal  and  intraretinal
emorrhage.  No  macroaneurysm  was  visualized.  The  patient
as  educated  on  the  importance  of  strict  blood  pressure
ontrol,  referred  to  her  primary  care  doctor  for  blood  pres-
ure  management  and  scheduled  for  a  retina  consultation  2
ays  later.
Clinical  presentation  and  acuities  were  unchanged  at  the
onsultation.  The  retinal  specialist  diagnosed  the  patient
ith  multilevel  retinal  hemorrhage  likely  secondary  to  RAM.
luorescein  angiography  (FA)  was  requested  to  evaluate
or  leakage  from  the  presumed  RAM.  FA  in  the  right  eye
as  unremarkable  except  for  a  focal  area  of  hyperﬂuo-
escence  superior-nasal  to  the  macular  region  consistent
ith  the  isolated  microaneurysm  seen  on  DFE.  The  left  eye
howed  complete  blockage  of  ﬂuorescein  in  the  macular
egion  (Fig.  2).  There  was  no  leakage  visible  in  the  pre-
umed  location  of  the  macroaneurysm,  making  a  diagnosis
f  RAM  inconclusive.  After  discussion  of  treatment  options
ith  the  patient,  including  observation  versus  risks  and  ben-
ﬁts  of  surgery,  a pars  plana  vitrectomy  (PPV)  procedure  was
lected  to  remove  the  pre-retinal  blood  for  improved  retinal
isibility  and  to  determine  a  deﬁnitive  diagnosis.
Two  weeks  after  PPV  the  patient  reported  a  subjec-
ive  improvement  in  her  vision  OS,  denied  any  pain  or
rritation,  and  was  overall  pleased  with  her  surgical  out-
ome.  Uncorrected  VA  measured  20/30  OD  with  pinhole  to
0/25  and  20/40  OS  without  pinhole  improvement.  Fundus-
opic  examination  OS  revealed  a resolving  retinal  arterial
acroaneurysm,  located  just  past  the  third  arterial  bifur-
ation  in  the  superior-temporal  arcades  (Fig.  3).  Residual
ubretinal  and  intraretinal  hemorrhage  remained  and  SD
CT  conﬁrmed  mild  retinal  edema  localized  to  1.5  disk
iameters  around  the  macroaneurysm,  sparing  the  macula.
Six  weeks  after  PPV,  she  noted  further  visual  improve-
ent  OS.  Uncorrected  VA  measured  20/30  OD  and  20/25
S.  Fundus  examination  OS  revealed  a small  amount  of
ehemoglobinized  blood  adjacent  to  the  arteriole  and  the
igure  2  Fluorescein  angiogram  of  the  left  eye  shows  block-
ge of  ﬂuorescein  by  the  preretinal  hemorrhage  and  no  leakage
s observed  from  the  presumed  location  of  the  RAM.
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Figure  3  Two  weeks  status-post  pars  plana  vitrectomy,  a
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Resolving  RAM  is  visible  along  the  superior-temporal  arcades
urrounded  by  resolving  sub-retinal  blood.
revious  areas  of  intraretinal  and  subretinal  hemorrhage
ere  replaced  by  a  circinate  pattern  of  exudation.  A
A  was  ordered  to  re-evaluate  for  leakage.  Evaluation  of
he  FA  revealed  a  z-shaped  kink  in  the  involved  arteriole
t  the  site  of  the  macroaneurysm  without  active  leakage.
The  patient  returned  for  follow-up  5  months  status-
ost  PPV  and  noted  stable  vision  since  the  previous  visit
nd  denied  any  medical  changes.  Best  corrected  acuities
easured  20/20  OD  and  20/20  OS.  Fundus  examination  OS
evealed  continued  resolution  of  the  RAM.  Mild  exudate
emained  in  a  circinate  pattern  with  a  small  amount  of
ehemoglobinazed  blood  adjacent  to  the  involved  arteriole
Fig.  4).
Over  the  course  of  her  follow-up  exams,  the  patient
nd  her  husband  were  repeatedly  educated  on  the  impor-
ance  of  BP  control  to  prevent  further  ocular  and
ystemic  complications.  The  patient  remained  unwilling  to
rovide  the  name  and  contact  information  for  her  primary
are  provider  (PCP).  However,  she  reported  scheduling  a
igure  4  Five  months  status-post  pars  plana  vitrectomy,  res-
lution  of  the  RAM  is  nearly  complete.A.M.  Speilburg,  S.A.  Klemencic
ollow-up  appointment  with  her  PCP  and  improved  compli-
nce  with  her  current  hypertensive  medications.
onclusion
etinal  arterial  macroaneurysm  may  present  a  diagnostic
ilemma  as  the  clinical  presentation  varies  greatly.  Patients
resenting  with  RAM  need  evaluation  by  their  primary
are  physician  for  hypertension,  lipid  and  arteriosclerosis
ontrol.3 Prognosis  is  good  and  observation  alone  is  usu-
lly  adequate  treatment,  but  in  cases  of  macular  threat
reatment  options  are  available  and  referral  to  a  retinal  spe-
ialist  is  indicated.  Accurate  diagnosis  and  co-management
re  crucial  to  save  vision  and  help  prevent  life  altering
omplications  from  uncontrolled  hypertension.
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